antazoline has been researched along with mecamylamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Beleslin, DB; Nedelkovski, V | 1 |
2 other study(ies) available for antazoline and mecamylamine
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Emesis induced by 4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium chloride (McN-A-343): evidence for a predominant central muscarinic M1 mediation.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; 5,6-Dihydroxytryptamine; alpha-Methyltyrosine; Animals; Antazoline; Bretylium Compounds; Cats; Chlorpromazine; Choline; Emetics; Female; Hemicholinium 3; Hexamethonium Compounds; Injections, Intraventricular; Male; Mecamylamine; Methyltyrosines; Methysergide; Neuromuscular Blocking Agents; Propranolol; Quaternary Ammonium Compounds; Receptors, Muscarinic; Reserpine; Yohimbine | 1988 |